Terms: = Prostate cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Diagnosis
15 results:
1. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
2. Meta-analysis of
Yu W; Zhao M; Deng Y; Liu S; Du G; Yan B; Zhao Z; Sun N; Guo J
Cancer Imaging; 2023 Aug; 23(1):77. PubMed ID: 37605288
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of short biparametric magnetic resonance imaging protocol in men at risk of prostate cancer.
Faccioli N; Santi E; Foti G; Curti P; D'Onofrio M
Arch Ital Urol Androl; 2022 Jun; 94(2):160-165. PubMed ID: 35775339
[TBL] [Abstract] [Full Text] [Related]
4. MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
He D; Wang X; Fu C; Wei X; Bao J; Ji X; Bai H; Xia W; Gao X; Huang Y; Hou J
Cancer Imaging; 2021 Jul; 21(1):46. PubMed ID: 34225808
[TBL] [Abstract] [Full Text] [Related]
5. New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown.
Kempf E; Lamé G; Layese R; Priou S; Chatellier G; Chaieb H; Benderra MA; Bellamine A; Bey R; Bréant S; Galula G; Taright N; Tannier X; Guyet T; Salamanca E; Audureau E; Daniel C; Tournigand C;
Eur J Cancer; 2021 Jun; 150():260-267. PubMed ID: 33940350
[TBL] [Abstract] [Full Text] [Related]
6. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract] [Full Text] [Related]
7. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
Schmidt B; Eapen RS; Cowan JE; Broering JM; Greene KL; Carroll PR; Cooperberg MR
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):117-124. PubMed ID: 30171230
[TBL] [Abstract] [Full Text] [Related]
8. Peripheral zone volume ratio (PZ-ratio) is relevant with biopsy results and can increase the accuracy of current diagnostic modality.
Chang Y; Chen R; Yang Q; Gao X; Xu C; Lu J; Sun Y
Oncotarget; 2017 May; 8(21):34836-34843. PubMed ID: 28422738
[TBL] [Abstract] [Full Text] [Related]
9. Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer.
Quek RG; Master VA; Portier KM; Ward KC; Lin CC; Virgo KS; Lipscomb J
Urol Oncol; 2014 Aug; 32(6):748-60. PubMed ID: 24840868
[TBL] [Abstract] [Full Text] [Related]
10. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
Rieken M; Kluth LA; Xylinas E; Fajkovic H; Becker A; Karakiewicz PI; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Pummer K; Lee RK; Faison T; Scherr DS; Kautzky-Willer A; Bachmann A; Tewari A; Shariat SF
World J Urol; 2014 Aug; 32(4):999-1005. PubMed ID: 24062093
[TBL] [Abstract] [Full Text] [Related]
11. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types.
Zucca AC; Boyes AW; Linden W; Girgis A
J Pain Symptom Manage; 2012 Apr; 43(4):720-31. PubMed ID: 22277904
[TBL] [Abstract] [Full Text] [Related]
12. Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.
Yu YY; Pinsky PF; Caporaso NE; Chatterjee N; Baumgarten M; Langenberg P; Furuno JP; Lan Q; Engels EA
Arch Intern Med; 2008 Nov; 168(21):2326-32; discussion 2332. PubMed ID: 19029496
[TBL] [Abstract] [Full Text] [Related]
13. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
[TBL] [Abstract] [Full Text] [Related]
14. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348
[TBL] [Abstract] [Full Text] [Related]
15. Screening for prostate cancer. Comparison of transrectal ultrasound, prostate specific antigen and rectal examination.
Perrin P; Maquet JH; Bringeon G; Devonec M
Br J Urol; 1991 Sep; 68(3):263-5. PubMed ID: 1717096
[TBL] [Abstract] [Full Text] [Related]
